Prospective Cohort Study of Children Diagnosed with Type 1 Diabetes in Türkiye Between 2018 to 2022
Launched by TURKISH PEDIATRIC DIABETES WORKING GROUP · Mar 22, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes mellitus can develop in individuals between the ages of 2 months and 18 years.
- Exclusion Criteria:
- • other types of diabetes mellitus
About Turkish Pediatric Diabetes Working Group
The Turkish Pediatric Diabetes Working Group is a collaborative network of healthcare professionals dedicated to advancing the understanding and management of diabetes in children and adolescents. Comprising pediatric endocrinologists, researchers, and allied health specialists, the group focuses on conducting clinical trials and research initiatives aimed at improving treatment protocols and outcomes for young patients with diabetes. By fostering a multidisciplinary approach and promoting best practices, the Working Group seeks to enhance clinical care, support innovation, and contribute to the global knowledge base on pediatric diabetes management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported